Det var derfor CHMP' s holdning, at de fremlagte data var tilstrækkelige til at omfatte den terapeutiske indikation "infektioner i knogler og led" i markedsføringstilladelserne for ciprofloxacin, og CHMP bemærkede, at produktresuméet bør give klar besked om behovet for samtidig administration af et eller flere passende antimikrobielle stoffer.
Therefore, the CHMP considered that the data provided was sufficient to include the therapeutic indication “ Infections of the bones and joints” in Ciprofloxacin Marketing Authorisations, and noted that the SPC should give a clear message on the need for co-administration with appropriate antibacterial agent(s).